psoriasis: An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
8220 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1188 |
4. Check minimum number of eventsNone |
1188 |
5. Include endpointsNone |
1188 |
6. Filter based on genotype QC (FinnGen only) |
1188 |
Control definitions (FinnGen only)
- Control exclude
- L12_PAPULOSQUAMOUS
- Control conditions
- not L12_PSORI_VULG
Extra metadata
- First used in FinnGen datafreeze
- DF3
Similar endpoints
↥List of similar endpoints to
Psoriasis (vulgaris), strict definition
based on the number of shared cases.
Similar with more cases:
- Psoriasis vulgaris
- Psoriasis
- Papulosquamous disorders
- Autoimmune diseases related-to ILD
- Autoimmune diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4808 | 1617 | 3168 |
| Only index persons | 4482 | 1538 | 2944 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.05 | 0.09 |
| Only index persons | 0.09 | 0.06 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 51.67 | 54.18 | 50.42 |
| Only index persons | 51.17 | 53.78 | 49.80 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1188 | 482 | 706 |
| Unadjusted period prevalence (%) | 0.25 | 0.16 | 0.31 |
| Median age at first event (years) | 51.75 | 53.04 | 50.87 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1003
- Matched controls
- 10029
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D07AC01
ATC
betamethasone; topical
22.2
323.0
855
2067
D07XC01
ATC
betamethasone, combinations; topical
76.2
323.0
805
508
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
1380.4
323.0
411
5
D05AX03
ATC
calcitriol; topical
216.1
323.0
333
23
D07AD01
ATC
clobetasol; topical
30.0
323.0
676
647
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
+∞
323.0
667
*
L40.0
ICD-10 Finland
Psoriasis vulgaris
7799.2
323.0
965
26
134
Kela drug reimbursment
General erythroderma
2507.4
323.0
331
*
L40.5
ICD-10 Finland
Arthropathic psoriasis
1611.8
323.0
394
*
E0000UV
ATC
NA
38.0
323.0
927
2437
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
121.5
323.0
811
336
E000001
ATC
NA
18.5
323.0
682
1034
D05BB02
ATC
acitretin; oral
646.3
323.0
651
29
D05AX52
ATC
calcipotriol, combinations; topical
394.3
323.0
843
132
D05AX02
ATC
calcipotriol; topical
243.1
323.0
684
88
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
+∞
252.0
231
*
L04AB04
ATC
adalimumab; parenteral
63.9
238.3
275
59
L04AC05
ATC
ustekinumab; parenteral
424.0
235.9
228
7
D07AC13
ATC
mometasone; topical
9.2
223.6
670
1793
L40
ICD-10 Finland
Psoriasis
87.7
219.3
241
36
L40.9
ICD-10 Finland
Psoriasis, unspecified
206.3
210.1
212
13
L04AC10
ATC
secukinumab; parenteral
487.1
205.2
198
5
L04AA32
ATC
apremilast; oral
+∞
202.1
187
*
E000003
ATC
NA
26.2
198.3
284
149
M07.3
ICD-10 Finland
Other psoriatic arthropathies
751.5
193.9
185
*
E000002
ATC
NA
11.8
192.8
401
535
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
34.2
190.0
251
97
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
12.1
175.5
354
433
D07AB02
ATC
hydrocortisone butyrate; topical
7.2
175.1
586
1637
L04AC16
ATC
guselkumab; systemic
+∞
170.8
159
*
L40.8
ICD-10 Finland
Other psoriasis
1822.0
160.9
152
*
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
88.6
159.8
176
24
TQW80
NOMESCO Finland
Local dermatologic skincare
32.6
150.0
200
76
L04AD01
ATC
ciclosporin; systemic
34.2
142.9
188
67
D07AB08
ATC
desonide; topical
9.5
142.5
327
484
S91
ICPC
Psoriasis
232.0
138.7
140
7
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
6.2
138.4
478
1278
L04AC13
ATC
ixekizumab; parenteral
+∞
136.7
128
*
D02AE01
ATC
carbamide; topical
11.8
129.8
257
284
6961A
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]
+∞
106.2
100
*
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
+∞
102.9
97
*
D05AA
ATC
Tars
144.8
99.1
104
8
L04AB01
ATC
etanercept; parenteral
34.4
97.1
127
42
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.0
94.2
234
368
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
9.3
88.5
197
257
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
8.1
86.7
212
322
D02AX
ATC
Other emollients and protectives
15.8
85.6
144
105
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.7
82.0
588
2791
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
19.9
81.9
126
72
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
18.6
81.9
129
79
E000007
ATC
NA
9.0
77.1
173
226
E000006
ATC
NA
8.2
73.1
175
253
L40.4
ICD-10 Finland
Guttate psoriasis
738.2
71.0
69
*
A07EC01
ATC
sulfasalazine; oral, rectal
6.9
70.6
191
330
L04AC18
ATC
risankizumab; parenteral
+∞
69.6
66
*
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
703.7
67.8
66
*
299
Kela drug reimbursment
NA
+∞
66.4
63
*
L04AA01
ATC
[U] ciclosporin; systemic
19.7
62.0
95
53
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
7.0
61.1
162
269
D07AA02
ATC
hydrocortisone; topical
4.4
59.1
249
706
XQ848
NOMESCO Finland
Dermatological photography
14.0
55.9
98
77
D05AX05
ATC
tazarotene; topical
+∞
55.7
53
*
L04AA13
ATC
leflunomide; oral
16.2
53.6
88
59
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.8
45.3
166
401
D09AB01
ATC
zinc bandage without supplements; topical
14.6
44.0
75
55
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
31.6
40.9
54
18
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
39.9
38
*
L04AA11
ATC
[U] etanercept; parenteral
42.9
39.7
49
12
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
60.1
39.6
46
8
H02AB06
ATC
prednisolone; systemic
2.4
38.4
520
3097
M07.0
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
+∞
37.7
36
*
D05AC01
ATC
dithranol; topical
131.5
35.9
38
*
D05AX
ATC
Other antipsoriatics for topical use
+∞
34.6
33
*
L40.1
ICD-10 Finland
Generalized pustular psoriasis
+∞
34.6
33
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.3
34.4
480
2844
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
3.2
32.0
188
672
TQW99
NOMESCO Finland
Other minor procedure on skin
5.8
30.0
88
163
L26
ICD-10 Finland
Exfoliative dermatitis
85.3
29.9
33
*
L04AC
ATC
Interleukin inhibitors
+∞
27.2
26
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.6
27.1
134
417
J01DB01
ATC
cefalexin; oral
2.4
26.1
843
6878
L88
ICPC
Rheumatoid/seropositive arthritis
7.0
25.9
65
98
D07AC14
ATC
methylprednisolone aceponate; topical
4.6
23.2
83
192
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
8.5
23.1
51
63
D07BC01
ATC
betamethasone and antiseptics; topical
2.9
23.0
158
616
M07.2*L40.5
ICD-10 Finland
Psoriatic spondylitis
+∞
23.0
22
*
D07XB01
ATC
flumetasone, combinations; topical
23.6
22.7
32
14
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.1
22.2
323
1850
D07BA04
ATC
hydrocortisone and antiseptics; topical
3.0
21.0
130
474
N05BB01
ATC
hydroxyzine; systemic
3.6
20.9
97
286
D07CC01
ATC
betamethasone and antibiotics; topical
2.6
19.9
165
716
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
19.9
238
1242
E000004
ATC
NA
7.0
19.5
48
71
J01FF01
ATC
clindamycin; systemic
2.0
19.3
305
1787
RJ421
NOMESCO Finland
NA
26.6
19.2
26
10
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
+∞
18.8
18
*
M25.5
ICD-10 Finland
Pain in joint
2.0
18.6
290
1688
R06AE07
ATC
cetirizine; oral
1.8
18.3
428
2880
ZX112
NOMESCO Finland
Subcutaneous
7.3
18.3
44
63
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
5.5
18.2
54
102
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.9
18.1
401
2649
A10BA02
ATC
metformin; oral
2.0
18.0
279
1616
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
11.3
17.8
33
30
RJ411
NOMESCO Finland
NA
16.0
17.6
28
18
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.7
17.2
78
226
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
6.4
16.8
44
71
69600
ICD-8 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
16.7
16
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.2
16.6
180
891
D11AH04
ATC
alitretinoin; oral
172.7
16.5
17
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
6.5
16.5
43
69
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.9
16.4
102
371
NH3EA
NOMESCO Finland
Feet X-ray examination with load
7.2
16.2
39
56
E66.8
ICD-10 Finland
Other obesity
3.6
16.2
74
216
A46
ICD-10 Finland
Erysipelas
2.3
16.1
159
752
WQ031
NOMESCO Finland
NA
162.4
15.5
16
*
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
7.4
15.4
36
50
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
15.2
265
1586
A10BJ06
ATC
semaglutide; parenteral
4.4
14.8
54
129
E66.01
ICD-10 Finland
Obesity due to excess calories
2.8
14.7
99
380
T90
ICPC
Diabetes non-insulin dependent
2.0
14.7
232
1339
L04AA21
ATC
efalizumab; parenteral
+∞
14.6
14
*
WQ053
NOMESCO Finland
NA
+∞
14.6
14
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.9
14.5
252
1503
WQ066
NOMESCO Finland
NA
152.1
14.5
15
*
SPAT1263
SPAT
Sampling
1.7
14.4
393
2720
J01DA01
ATC
[U] cefalexin; systemic
1.7
14.3
603
4730
D07AC03
ATC
desoximetasone; topical
6.3
14.0
37
61
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.4
13.7
66
201
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
5.7
13.4
38
69
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
13.2
491
3682
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
13.2
246
1501
C08CA01
ATC
amlodipine; oral
1.7
12.7
303
1997
RS340
NOMESCO Finland
NA
32.5
12.6
16
5
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
12.6
132
641
L40.2
ICD-10 Finland
Acrodermatitis continua
131.6
12.5
13
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.1
12.3
155
814
XQ802
NOMESCO Finland
Epicutan test
3.6
12.2
55
160
M01AH05
ATC
etoricoxib; oral
1.6
11.9
580
4619
RJ420
NOMESCO Finland
NA
14.9
11.8
19
13
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
11.8
126
614
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.2
11.7
126
617
SPAT1262
SPAT
Handing over of treatment supplies
1.9
11.6
188
1085
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
8.2
11.6
25
31
E66.00
ICD-10 Finland
Metabolic syndrome
2.8
11.4
74
275
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.4
11.3
100
448
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
4.9
11.2
36
76
L04AB05
ATC
certolizumab pegol; parenteral
18.0
10.7
16
9
WZC30
NOMESCO Finland
Teaching
2.0
10.6
137
723
XQ800
NOMESCO Finland
Prick test
2.5
10.6
84
355
M07.1*L40.5
ICD-10 Finland
Arthritis mutilans
+∞
10.4
10
*
TNG10
NOMESCO Finland
Puncture of knee
7.8
10.4
23
30
A10BH01
ATC
sitagliptin; oral
2.3
10.2
98
456
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.1
10.2
128
667
L04AB06
ATC
golimumab; parenteral
8.6
10.1
21
25
J02AC01
ATC
fluconazole; systemic
1.6
9.9
314
2211
A02BC02
ATC
pantoprazole; systemic
1.5
9.9
583
4758
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
9.9
91
416
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
9.8
59
213
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
3.8
9.8
40
108
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.3
9.8
89
403
SPAT1301
SPAT
No procedures
1.6
9.7
269
1824
ZXC50
NOMESCO Finland
Cryotherapy
4.0
9.7
37
94
N02AX02
ATC
tramadol; systemic, rectal
1.6
9.6
380
2823
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
9.6
129
693
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
4.7
9.4
31
68
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
9.4
399
3010
H02AB07
ATC
prednisone; oral
2.0
9.4
130
708
L43.8
ICD-10 Finland
Other lichen planus
21.9
9.4
13
6
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.1
9.3
107
539
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
10.8
9.3
17
16
H04.10
ICD-10 Finland
Dry eye syndrome
2.3
9.3
84
380
C03CA01
ATC
furosemide; systemic
1.7
9.2
194
1213
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
9.1
233
1543
R5140
NOMESCO Finland
Monitoring the use of the aid
2.0
9.1
116
610
C07AB07
ATC
bisoprolol; oral
1.5
9.1
379
2839
G47.3
ICD-10 Finland
Sleep apnoea
1.7
9.1
228
1502
D01AC02
ATC
miconazole; topical
2.3
9.0
82
372
NG1DA
NOMESCO Finland
X-ray of knees
5.8
8.9
24
42
D07XB05
ATC
dexamethasone, combinations; topical
3.7
8.9
37
102
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
12.7
8.9
15
12
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
5.7
8.8
24
43
R06AX27
ATC
desloratadine; oral
1.6
8.7
242
1638
M13.9
ICD-10 Finland
Arthritis, unspecified
2.4
8.7
72
312
160
Kela drug reimbursment
exenatide
3.9
8.7
34
89
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
4.4
8.7
30
70
S02CA02
ATC
flumetasone and antiinfectives; otic
2.7
8.6
56
213
J01CE08
ATC
benzathine benzylpenicillin; parenteral
8.3
8.6
18
22
XQ899
NOMESCO Finland
Other assessment of skin
16.4
8.6
13
8
M04AA01
ATC
allopurinol; systemic
2.0
8.5
110
582
D05AD01
ATC
trioxysalen; topical
90.8
8.4
9
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
8.4
427
3325
L20.0
ICD-10 Finland
Besnier prurigo
2.4
8.4
67
285
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
8.3
345
2570
WZA90
NOMESCO Finland
Other doctors statement
1.6
8.3
212
1403
L30.3
ICD-10 Finland
Infective dermatitis
3.2
8.2
41
131
R03AC02
ATC
salbutamol; inhalant
1.5
8.2
453
3587
291
Kela drug reimbursment
Tofacitinib
17.3
8.1
12
7
N02BE01
ATC
paracetamol; systemic, rectal
1.6
8.1
791
7063
WX110
NOMESCO Finland
Local anesthesy
1.5
8.1
649
5545
J01CE02
ATC
phenoxymethylpenicillin; oral
1.5
8.0
667
5731
S18
ICPC
Laceration/cut
1.5
8.0
364
2760
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
7.3
8.0
18
25
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
7.3
8.0
18
25
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
7.9
151
914
M01CB03
ATC
auranofin; oral
9.5
7.8
15
16
EBA00
NOMESCO Finland
Extraction of tooth
1.5
7.8
300
2192
RS221
NOMESCO Finland
NA
5.3
7.7
22
42
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.2
7.7
39
127
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
7.7
342
2580
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
7.6
243
1694
WW200
NOMESCO Finland
Immunization
3.2
7.6
38
122
S97
ICPC
Chronic ulcer skin
2.6
7.6
52
203
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
12.0
7.6
13
11
D06BB04
ATC
podophyllotoxin; topical
2.4
7.5
61
261
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.6
7.5
244
1710
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.4
7.5
59
251
WQ054
NOMESCO Finland
NA
80.7
7.4
8
*
L57.0
ICD-10 Finland
Actinic keratosis
2.3
7.4
67
306
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.1
7.4
39
131
L04AC12
ATC
brodalumab; systemic
+∞
7.3
7
*
W0X00
NOMESCO Finland
Estimation of continuous need for medical therapy
+∞
7.3
7
*
R06AE09
ATC
levocetirizine; oral
1.8
7.3
131
780
L04AA29
ATC
tofacitinib; oral
15.9
7.2
11
7
SPAT1254
SPAT
Administration of medicine
1.8
7.2
118
681
D07AB01
ATC
clobetasone; topical
3.0
7.2
39
134
L04AA17
ATC
[U] adalimumab; parenteral
20.2
7.1
10
5
205
Kela drug reimbursment
Chronic hypertension
1.6
7.1
212
1454
B03BA03
ATC
hydroxocobalamin; parenteral
2.7
7.1
47
182
J01FA06
ATC
roxithromycin; oral
1.5
7.1
341
2603
4AA12
NOMESCO Finland
NA
12.1
7.1
12
10
R4180
NOMESCO Finland
Podiatric therapy
5.7
7.1
19
34
SPAT1312
SPAT
General health counselling
1.5
7.0
276
2021
L20
ICPC
Joint symptom/complaint NOS
3.1
7.0
35
114
RF120
NOMESCO Finland
NA
5.9
6.9
18
31
RF410
NOMESCO Finland
NA
5.9
6.9
18
31
J01CF05
ATC
flucloxacillin; systemic
2.7
6.9
44
165
RS121
NOMESCO Finland
NA
8.3
6.8
14
17
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
6.8
87
458
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
6.2
6.8
17
28
WQ021
NOMESCO Finland
NA
40.3
6.8
8
*
3005
Kela drug reimbursment
Tofacitinib
16.8
6.8
10
6
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.7
438
3534
A10BB12
ATC
glimepiride; oral
2.3
6.7
59
264
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.4
6.7
56
243
M54.5
ICD-10 Finland
Low back pain
1.5
6.7
283
2096
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.6
6.7
28
79
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.9
6.6
25
65
SPAT1325
SPAT
Vaccination
1.5
6.6
251
1820
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
6.6
296
2221
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
4.4
6.6
22
51
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.8
6.5
112
656
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
6.5
173
1153
SPAT1310
SPAT
Counselling related to known health issue
1.5
6.5
265
1948
RD210
NOMESCO Finland
NA
4.3
6.4
22
52
QXA70
NOMESCO Finland
Guidance related to rash and skin care
70.3
6.4
7
*
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
14.4
6.4
10
7
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
6.4
241
1739
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.4
324
2490
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.7
6.4
41
155
WZA00
NOMESCO Finland
Short statement of of health and health related matters
2.3
6.4
59
270
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
6.4
78
407
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.8
6.4
38
139
R03BA05
ATC
fluticasone; inhalant
1.6
6.4
151
975
R05
ICPC
Cough
1.6
6.3
174
1167
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.6
6.3
42
164
RS211
NOMESCO Finland
NA
11.1
6.3
11
10
R06.0
ICD-10 Finland
Dyspnoea
1.6
6.3
192
1323
M073L
ICD-10 Finland
NA
+∞
6.3
6
*
L405M
ICD-10 Finland
NA
+∞
6.3
6
*
C08CA03
ATC
isradipine; systemic
7.1
6.2
14
20
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
4.0
6.2
23
59
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
6.1
229
1650
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
6.1
373
2963
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
6.1
225
1616
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.3
6.1
50
219
RF420
NOMESCO Finland
NA
4.9
6.1
18
37
J01AA02
ATC
doxycycline; systemic
1.4
6.1
705
6266
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
3.6
6.0
25
71
S29
ICPC
Skin symptom/complaint other
1.7
6.0
129
808
H02AB04
ATC
methylprednisolone; systemic
1.7
6.0
123
763
S76
ICPC
Skin infection other
2.4
6.0
49
213
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
390
264
21.50
307.65
1.8
1.6
iu/ml
0.2
0.1
0.21
55
48
(3001604) Monocytes [#/volume] in Blood
1096
4623
18.70
272.31
15.5
5.8
e9/l
0.6
0.6
4.55
1080
4003
(3006315) Basophils [#/volume] in Blood
1097
4640
18.81
271.52
15.5
5.9
e9/l
0.0
0.0
8.69
1081
4021
(3019198) Lymphocytes [#/volume] in Blood
1099
4773
18.39
260.74
15.6
5.9
e9/l
2.1
2.0
0.53
1087
4219
(3013115) Eosinophils [#/volume] in Blood
1097
4805
17.75
256.19
15.9
6.2
e9/l
0.2
0.2
4.58
1081
4234
(3021879) Hepatitis B virus core Ab [Presence] in Serum
429
771
8.14
247.60
1.2
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1016
4208
10.77
246.50
15.9
6.1
%
0.8
0.7
10.35
1011
3937
(3006504) Eosinophils/100 leukocytes in Blood
1021
4345
10.60
237.35
15.8
6.0
%
3.1
2.9
3.33
1016
4055
(3019069) Monocytes/100 leukocytes in Blood
1022
4371
10.58
235.71
16.3
6.3
%
9.0
8.6
3.62
1017
4103
(3037522) Nuclear Ab [Titer] in Serum
541
1293
6.85
234.44
1.4
1.3
titre
427.3
495.0
0.32
98
245
(42870588) Differential panel, method unspecified - Blood
841
3052
7.01
229.22
13.2
5.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1025
4509
10.28
225.50
16.1
6.0
%
30.3
28.3
9.27
1019
4214
(3018010) Neutrophils/100 leukocytes in Blood
1017
4449
9.93
224.69
15.6
5.8
%
55.5
56.9
3.94
1012
4176
(3013650) Neutrophils [#/volume] in Blood by Automated count
1102
5352
15.63
214.75
17.3
9.2
e9/l
3.9
4.1
3.79
1085
4665
(3025159) Blasts/100 leukocytes in Blood
355
651
7.35
197.37
5.6
4.6
%
0.0
0.1
0.91
71
177
(3021440) Promyelocytes/100 leukocytes in Blood
364
698
7.08
193.48
5.6
4.6
%
0.0
0.2
2.77
82
211
(3002179) Metamyelocytes/100 leukocytes in Blood
356
672
7.14
192.06
5.1
4.3
%
0.4
0.4
0.36
64
169
(3017181) Myelocytes/100 leukocytes in Blood
371
745
6.79
187.90
5.5
4.4
%
0.5
0.9
2.45
83
233
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
504
1468
5.23
166.50
1.4
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
616
2160
4.85
160.01
9.2
4.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
442
1196
5.29
158.53
1.4
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
93
24
41.96
153.38
1.6
1.3
ug/l
9.2
9.7
0.21
93
24
(46235355) HIV 1 and 2 tests - Meaningful Use set
515
1867
4.10
121.22
1.5
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1081
6846
7.43
110.56
8.1
3.8
mm/h
12.6
10.6
5.11
1043
6381
(3021589) Normoblasts [#/volume] in Blood
808
4179
3.92
108.30
17.7
9.2
e9/l
0.0
0.0
0.66
782
3426
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1105
7184
8.70
108.21
13.1
7.5
u/l
78.6
77.2
0.60
1090
6790
(3030905) Polymorphonuclear cells [#/volume] in Blood
131
173
8.39
95.05
3.1
3.6
e9/l
3.9
4.4
1.35
131
173
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
131
178
8.15
92.75
3.2
4.0
%
54.5
57.0
1.34
131
178
(3015171) Extractable nuclear Ab [Units/volume] in Serum
182
352
5.92
92.09
1.1
1.2
u/ml
1.4
1.1
—
7
28
(3009871) Measles virus Ab [Titer] in Serum
66
30
23.24
90.27
2.0
1.5
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
55
29
19.84
70.49
1.4
2.1
mg/l
7.3
9.3
0.86
36
24
(3037467) Urinalysis macro (dipstick) panel - Urine
941
6266
3.41
67.51
5.8
3.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
133
277
5.28
61.32
1.7
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
146
330
4.90
61.19
1.4
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
732
4475
2.66
57.20
5.0
3.2
estimate
0.0
0.0
0.50
226
840
(3021601) Nitrite [Presence] in Urine by Test strip
734
4496
2.66
57.08
6.6
4.3
estimate
0.0
0.0
0.50
236
861
(3009261) Glucose [Presence] in Urine by Test strip
736
4533
2.64
56.28
5.0
3.2
estimate
0.0
0.0
1.08
216
803
(3014148) Varicella zoster virus Ab [Titer] in Serum
78
120
6.89
48.97
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
443
2325
2.44
45.13
13.2
6.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
448
2391
2.40
43.66
5.6
3.5
estimate
0.0
0.0
1.08
223
831
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
77
132
6.17
43.49
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
262
1136
2.68
39.24
1.6
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
444
2493
2.25
37.16
3.1
2.6
umol/l
4243.0
6372.2
0.53
402
2211
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
568
3539
2.16
36.37
5.6
3.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
519
3149
2.15
35.30
4.1
3.5
e6/l
43.2
75.4
1.07
412
2240
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1141
9722
5.39
34.73
20.9
12.9
mg/l
15.9
23.6
20.83
1014
7590
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
95
239
4.23
34.40
1.5
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
332
1733
2.27
32.42
3.5
2.6
mosm/kgh2o
574.0
567.5
0.20
308
1497
(3007853) Bacteria identified in Skin by Aerobe culture
237
1082
2.49
31.29
2.1
1.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
50
77
6.73
31.27
1.6
1.4
%
45.0
31.8
1.10
27
54
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
298
1512
2.30
30.96
1.3
1.3
u/ml
7.6
10.7
0.38
115
636
(3000850) Epithelial cells [#/volume] in Urine
344
1854
2.20
30.84
3.3
2.5
e6/l
4.2
5.0
0.57
324
1642
(3041096) Erythrocytes [Presence] in Urine by Automated
436
2578
2.09
30.72
4.6
2.9
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
97
288
3.58
27.74
1.2
1.2
titre
287.1
90.4
—
7
24
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
52
96
5.62
27.13
1.8
1.6
%
42.5
59.4
1.58
28
68
(3004809) Band form neutrophils/100 leukocytes in Blood
61
133
4.78
26.39
1.8
3.8
%
0.8
1.4
0.83
50
114
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
670
4777
1.92
26.27
6.1
6.6
umol/l
12.0
11.8
0.12
638
4551
(3002582) Erythrocytes [#/volume] in Urine
436
2701
1.97
26.04
3.6
3.1
e6/l
45.6
79.2
0.62
382
2073
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
537
3613
1.89
24.64
2.6
2.2
nmol/l
72.3
74.8
1.19
495
3286
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
33
42
8.05
24.36
1.2
1.0
miu/ml
1124.1
1571.3
1.62
33
42
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
493
3240
1.89
24.22
4.3
3.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
80
230
3.66
23.98
1.2
1.2
u/ml
6.2
9.8
—
9
40
(3020682) Albumin/Creatinine [Ratio] in Urine
437
2769
1.91
23.96
4.4
4.0
mg/mmol
13.0
8.7
0.81
292
1821
(40761536) Microorganisms panel - Urine sediment
173
768
2.47
23.86
4.6
3.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
79
226
3.67
23.85
1.2
1.2
u/ml
8.3
2.3
—
5
23
(3007164) IgA [Mass/volume] in Serum or Plasma
327
1879
2.02
23.85
1.5
1.4
g/l
3.3
2.5
5.63
212
1220
(3010144) Erythrocytes [#/volume] in Synovial fluid
45
85
5.46
22.91
1.5
1.3
e6/l
19156.0
137557.3
0.89
33
62
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
488
3258
1.84
22.33
4.3
3.4
u/l
41.6
33.2
2.41
466
3101
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
285
1603
2.02
21.81
1.3
1.3
iu/ml
20.5
31.0
1.50
76
504
(3030467) Casts [#/volume] in Urine by Automated count
391
2451
1.89
21.72
3.6
3.0
e6/l
0.3
0.5
0.62
342
1838
(36304419) Bacteria [Presence] in Urine
388
2433
1.88
21.49
3.4
2.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
538
3736
1.80
21.36
5.0
5.1
g/l
35.3
36.1
2.46
500
3505
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
180
857
2.30
21.08
3.3
2.3
g/l
0.2
0.2
0.54
169
805
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1070
9293
2.52
20.97
22.0
11.6
ml/min/173m2
88.8
85.4
5.85
978
7654
(3012516) Albumin [Mass/volume] in Urine
408
2617
1.85
20.93
3.3
3.3
mg/l
581.7
231.2
0.63
263
1745
(3009508) Creatinine [Moles/volume] in Urine
438
2890
1.82
20.37
3.3
3.3
mmol/l
8.2
8.3
0.06
361
2466
(3000475) Leukocytes [#/volume] in Synovial fluid
71
211
3.52
20.24
1.9
1.6
e6/l
12744.4
17001.0
0.28
57
155
(3027945) Reticulocytes/100 erythrocytes in Blood
181
878
2.25
20.23
2.8
2.9
%
1.8
1.8
0.05
168
794
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
70
207
3.53
20.11
1.1
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
137
593
2.48
19.82
1.4
1.8
g/l
1.3
1.3
0.17
127
553
(3042936) Bacteria identified in Isolate by Culture
242
1327
2.03
19.67
2.3
2.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
64
191
3.48
18.13
5.7
4.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
125
542
2.46
17.98
1.7
2.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
365
2350
1.80
17.97
4.7
4.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
296
1792
1.87
17.77
1.6
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
325
2042
1.81
17.24
2.5
2.1
mg/l
3.3
2.9
2.15
284
1758
(3013826) Glucose [Moles/volume] in Serum or Plasma
692
5366
1.69
17.06
5.1
5.2
mmol/l
7.0
6.7
2.54
650
5043
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1148
10530
3.68
16.63
25.7
9.6
u/l
35.1
29.1
18.95
1142
10221
(3020630) Protein [Mass/volume] in Serum or Plasma
139
656
2.27
16.46
1.7
2.8
g/l
68.5
67.0
1.33
124
607
(3052851) Hemolysis interference index of Serum or Plasma
73
251
3.03
16.44
2.2
3.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
136
637
2.28
16.40
2.2
3.1
e9/l
73.8
73.2
0.08
114
486
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
57
171
3.45
16.03
1.1
1.1
iu/ml
54.6
81.9
0.19
12
43
(3011397) Hemoglobin [Presence] in Urine by Test strip
313
1989
1.78
15.78
5.3
3.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1023
8973
2.01
15.49
7.2
5.3
mmol/mol
41.1
39.5
5.01
961
8444
(3005719) IgG [Mass/volume] in Serum or Plasma
149
746
2.14
15.22
2.0
2.6
g/l
12.1
10.5
2.56
134
688
(3021788) Differential panel - Synovial fluid
53
158
3.46
15.06
1.7
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
330
2161
1.73
14.84
3.2
2.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
720
5768
1.63
14.53
5.0
3.8
e6/l
1862.4
2169.7
0.08
19
86
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
415
2903
1.66
14.52
3.0
2.6
u/l
56.1
57.4
0.27
381
2724
(3017354) Segmented neutrophils/100 leukocytes in Blood
35
80
4.48
14.33
2.0
3.7
%
56.6
54.1
0.25
24
59
(3008757) Leukocyte morphology finding [Identifier] in Blood
38
93
4.19
14.27
2.4
4.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
211
1229
1.87
13.98
2.3
2.4
g/l
2.5
2.3
1.91
195
1150
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
319
2099
1.71
13.98
1.3
1.2
u/ml
2.2
1.7
0.20
101
609
(3022948) Iron [Moles/volume] in Serum or Plasma
222
1327
1.83
13.51
2.5
2.4
umol/l
13.1
14.1
1.11
210
1232
(3000330) Specific gravity of Urine by Test strip
89
377
2.47
13.43
4.8
3.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
246
1527
1.77
13.17
2.0
2.0
%
1.7
1.5
4.00
227
1364
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
26
50
5.29
13.00
2.3
1.3
u/ml
30.2
13.9
—
5
7
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
465
3416
1.59
12.99
3.7
3.4
ng/l
26.8
44.9
2.40
312
2229
(3044941) Cell count panel - Synovial fluid
46
141
3.35
12.55
1.6
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1056
9535
1.97
12.21
5.6
3.8
mmol/l
1.6
1.4
10.20
1006
8896
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
166
942
1.89
11.83
2.4
4.7
u/l
222.5
238.3
1.27
156
892
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
551
4272
1.54
11.80
6.7
7.3
mmol/l
1.2
1.2
0.20
448
3636
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
70
282
2.58
11.74
1.9
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
74
307
2.50
11.68
1.1
1.3
miu/ml
208.3
207.7
0.00
20
139
(3013512) EKG study
357
2528
1.59
11.32
3.7
3.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
192
1155
1.79
11.31
2.5
2.4
ug/g
123.9
137.4
0.23
162
941
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
191
1148
1.79
11.29
2.4
2.5
%
22.6
24.4
0.85
165
1003
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
826
7036
1.57
11.24
4.9
3.2
u/l
78.2
50.0
6.43
778
6659
(3032080) INR in Blood by Coagulation assay
467
3535
1.53
10.92
8.9
8.2
inr
1.2
1.2
0.91
166
1052
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
450
3381
1.53
10.88
2.2
1.9
pmol/l
92.3
95.7
0.85
280
1828
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
260
1724
1.65
10.71
1.9
1.6
pmol/l
214884159.5
36236193.6
0.81
215
1493
(40760888) Immunoglobulin light chains.free panel - Serum
52
189
2.83
10.66
1.6
4.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
159
919
1.84
10.66
3.5
3.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
231
1490
1.68
10.57
2.9
3.7
mmol/l
0.8
0.8
1.38
213
1408
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
62
248
2.58
10.57
1.6
3.9
mg/l
48.2
31.0
0.88
45
194
(3034860) Kappa light chains.free [Mass/volume] in Serum
62
248
2.58
10.57
1.6
3.9
mg/l
52.9
74.5
0.35
43
194
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1080
9918
1.98
10.51
6.0
4.2
mmol/l
4.6
4.7
2.35
1033
9329
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
124
667
1.96
10.34
3.3
4.1
mmol/l
1.2
1.2
0.85
112
590
(3019150) Specific gravity of Urine by Refractometry
284
1962
1.59
9.80
6.1
3.4
kg/l
1.0
1.0
0.10
35
266
(3005322) IgE [Units/volume] in Serum or Plasma
115
615
1.96
9.75
1.5
1.3
u/ml
441.6
232.2
0.93
106
572
(3019309) Folate [Moles/volume] in Red Blood Cells
209
1383
1.62
8.53
2.0
1.7
nmol/l
1108.5
1168.3
0.45
166
1076
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
219
1469
1.60
8.44
2.7
2.7
e6/l
0.9
1.0
0.41
147
819
(40761535) Cells panel - Urine sediment
123
707
1.83
8.36
5.5
3.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
97
516
1.96
8.35
1.2
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
133
784
1.78
8.32
3.6
3.7
mmol/l
2.6
2.0
0.96
103
630
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1029
9440
1.67
8.32
5.1
4.2
mmol/l
6.2
5.9
7.18
963
8735
(3008898) HLA-B27 [Presence]
80
399
2.08
8.24
1.1
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
263
1852
1.54
8.18
1.8
1.5
nmol/l
19.8
20.6
0.27
224
1594
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
66
306
2.22
8.17
1.4
2.4
g/l
4.5
3.8
2.11
42
232
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
66
306
2.22
8.17
1.4
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
66
306
2.22
8.17
1.4
2.4
g/l
7.4
7.2
0.25
42
244
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
282
2.26
8.04
1.4
2.5
g/l
12.3
10.4
1.24
50
249
(3019550) Sodium [Moles/volume] in Serum or Plasma
1068
9914
1.76
8.03
17.8
14.5
mmol/l
139.3
139.7
5.55
1046
9685
(3023103) Potassium [Moles/volume] in Serum or Plasma
1072
9966
1.77
7.96
17.9
14.6
mmol/l
4.0
4.0
0.39
1047
9721
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
956
8646
1.54
7.90
4.8
4.3
mu/l
1.8
2.1
0.93
888
8013
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
71
345
2.13
7.83
1.9
2.0
ug/l
2.7
2.1
0.11
61
317
(40768797) Stomach Pathology biopsy report
187
1231
1.62
7.76
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
164
1047
1.66
7.68
1.4
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
808
7084
1.44
7.67
4.0
3.6
pmol/l
14.7
14.7
0.10
736
6510
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
104
583
1.86
7.66
1.6
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
142
877
1.70
7.53
2.6
2.2
nmol/l
314.1
367.7
3.31
133
825
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
75
378
2.05
7.52
4.0
3.6
%
46.0
49.5
0.52
75
373
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
70
349
2.07
7.24
1.2
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
43
174
2.53
7.23
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
32
111
2.94
7.20
3.1
3.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
478
3856
1.40
7.17
2.9
2.7
ug/l
138.9
137.2
0.06
446
3593
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
52
232
2.30
7.08
1.3
2.2
nmol/l
1.0
0.9
0.46
43
204
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1074
10048
1.72
7.02
5.8
4.6
mmol/l
2.8
2.8
1.26
1009
9394
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1059
9877
1.66
6.93
5.5
4.1
mmol/l
1.3
1.4
9.53
999
9249
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
305
2283
1.45
6.90
3.1
3.0
ng/l
863.2
1083.7
1.01
254
1917
(3017732) Neutrophils [#/volume] in Blood
110
650
1.76
6.83
3.9
3.1
e9/l
4.5
4.2
0.66
81
535
(3023183) Ammonium ion [Moles/volume] in Plasma
52
236
2.26
6.81
6.4
3.2
umol/l
39.3
34.2
0.84
42
202
(3037756) Immunofixation for Serum or Plasma
41
169
2.48
6.66
1.3
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
174
1170
1.57
6.56
5.0
6.6
mmol/l
1.0
1.0
0.42
166
1096
(3011436) Histone Ab [Units/volume] in Serum
11
18
6.16
6.43
1.4
1.1
u/ml
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1092
10302
1.74
6.40
19.3
11.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
37
149
2.53
6.32
3.8
3.2
u/ml
19.2
30.7
0.16
37
142
(3001729) Color of Synovial fluid
9
5
18.12
6.27
1.1
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
132
2.62
6.25
1.2
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
57
281
2.08
6.11
2.2
2.5
u/l
129.9
2947.2
2.23
14
115
(40768441) Liver Pathology biopsy report
21
63
3.38
6.01
1.4
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
26
91
2.90
5.80
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
27
97
2.82
5.75
2.6
2.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
42
188
2.28
5.72
1.2
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
278
2113
1.41
5.65
1.7
1.8
mg/l
1.3
1.0
0.50
213
1578
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
19
56
3.43
5.60
1.6
2.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
291
2.01
5.58
1.4
2.5
g/l
3.0
3.1
0.19
42
237
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
189
1339
1.49
5.58
1.7
1.9
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
25
88
2.88
5.53
14.0
9.2
mmol/l
8.0
7.3
0.29
19
74
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
63
3.21
5.33
1.6
2.3
%
18.9
15.2
—
8
30
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
157
1080
1.52
5.33
3.5
3.0
umol/l
10.2
8.4
0.31
140
953
(3045424) Erythrocytes [Presence] in Urine
39
175
2.27
5.30
1.1
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
464
3860
1.33
5.28
6.1
6.6
mmol/l
1.2
1.2
0.18
420
3542
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
113
725
1.62
5.19
3.4
2.5
ml/min/173m2
70.3
71.5
0.10
44
277
(44816559) Phosphatidylethanol [Mass/volume] in Blood
47
231
2.08
5.12
1.8
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
55
287
1.96
5.09
2.8
3.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
27
104
2.63
5.08
1.3
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
44
213
2.11
4.99
3.1
2.5
mmol/l
26.3
24.8
0.98
38
188
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
34
148
2.34
4.97
1.3
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
83
1329
0.60
4.96
1.3
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
32
4.10
4.90
4.2
5.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
91
562
1.67
4.86
3.3
3.4
kpa
5.3
5.2
0.61
82
525
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
20
67
3.02
4.84
1.2
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
24
4.62
4.78
1.7
1.8
—
—
—
0
0
(3009343) pH of Capillary blood
90
557
1.67
4.77
3.3
3.4
ph
7.4
7.4
0.03
14
72
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
58
3.14
4.65
1.3
1.4
u/l
16.8
5.2
—
6
25
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
337
2718
1.33
4.62
2.2
2.2
u/l
205.4
258.8
0.51
319
2585
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
50
262
1.95
4.60
1.5
2.7
g/l
0.6
1.0
0.48
42
242
(3003327) Ova and parasites identified in Stool by Light microscopy
57
314
1.86
4.52
1.7
1.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
23
87
2.68
4.50
1.2
1.2
u/l
50.1
52.2
0.10
15
60
(3037121) Protein [Mass/volume] in Urine
58
324
1.83
4.41
3.7
3.8
g/l
0.4
0.3
0.38
33
149
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
25
100
2.53
4.40
1.8
2.7
pg
32.6
32.8
0.04
25
100
(3024263) Appearance of Synovial fluid
16
50
3.23
4.34
2.2
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
10
22
4.58
4.31
1.3
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
476
4059
1.29
4.28
3.5
2.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
50
271
1.88
4.19
1.5
1.4
g/l
0.2
0.2
0.07
50
260
(3045414) Leukocytes [Presence] in Urine
65
383
1.74
4.15
1.5
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
35
168
2.12
4.10
1.7
2.2
g/l
127.2
132.5
0.79
25
127
(21494814) CD8 cells/100 lymphocytes in Specimen
12
32
3.78
4.09
1.8
2.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
84
533
1.62
4.08
3.3
3.4
mmol/l
1.5
1.6
0.09
64
401
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
152
1103
1.43
3.95
1.6
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
51
284
1.83
3.94
1.5
1.4
g/l
1.3
1.2
0.54
51
271
(3000570) Elastase.pancreatic [Mass/mass] in Stool
46
249
1.88
3.89
1.3
1.4
ug/g
245.0
291.5
0.99
28
137
(3021901) Oxygen saturation in Capillary blood
32
153
2.12
3.81
2.7
2.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
66
2.75
3.76
1.3
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
130
926
1.45
3.74
1.4
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
20
78
2.59
3.73
2.4
2.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
308
2519
1.30
3.72
3.6
4.2
ph
7.4
7.4
0.03
79
486
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
183
1390
1.37
3.66
2.7
2.9
e6/l
2.2
1.6
0.62
111
745
(3044889) 12 lead EKG panel
741
6745
1.26
3.65
3.6
3.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
60
360
1.70
3.63
1.6
2.2
g/l
1.5
1.5
0.03
48
312
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
45
248
1.85
3.62
1.5
2.6
g/l
37.2
38.2
0.42
37
220
(3006922) Hepatitis E virus Ab [Presence] in Serum
18
68
2.67
3.57
1.1
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
29
137
2.14
3.57
1.5
1.4
mmol/l
58.8
63.4
0.25
15
118
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
131
945
1.43
3.53
1.4
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
40
215
1.89
3.48
1.1
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
36
188
1.94
3.41
3.8
3.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
20
82
2.46
3.39
1.4
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
23
101
2.30
3.37
1.3
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
33
168
1.99
3.36
2.3
2.6
%
16.5
16.7
0.11
18
88
(3023511) Choriogonadotropin [Units/volume] in Urine
30
151
2.01
3.17
1.3
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
50
2.82
3.09
1.6
3.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
415
3592
1.24
3.04
2.0
2.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
287
2386
1.27
2.99
5.3
4.0
%
88.7
92.6
1.80
280
2329
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
63
2.56
2.96
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
63
2.56
2.96
1.1
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
30
157
1.93
2.87
2.3
3.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
30
158
1.92
2.82
1.3
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
39
224
1.77
2.80
1.3
1.9
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
24
3.77
2.67
1.4
2.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
39
229
1.73
2.62
1.3
1.9
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
18
80
2.27
2.61
1.1
1.3
g/l
6.2
6.9
0.48
12
57
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
85
604
1.44
2.54
3.6
4.0
ng/l
77.5
84.5
0.29
72
544
(3000012) Reticulocyte production index
10
33
3.05
2.53
1.6
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
19
88
2.18
2.52
1.3
2.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
62
415
1.52
2.49
3.8
3.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
33
188
1.78
2.47
5.2
4.7
mmol/l
2.1
2.5
0.47
23
132
(3000093) Morphology [Interpretation] in Blood Narrative
16
70
2.30
2.42
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
53
346
1.56
2.39
1.7
1.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
8
22
3.65
2.36
1.1
1.3
mmol/l
-0.5
2.1
—
8
22
(3013139) Helicobacter pylori Ag [Presence] in Stool
81
581
1.42
2.32
1.3
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
33
192
1.74
2.32
4.4
3.5
mg/l
19.5
22.4
0.22
24
118
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
727
6763
1.19
2.30
3.0
3.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
302
2600
1.22
2.24
1.9
1.6
mmol/l
1.6
1.5
2.84
249
2226
(3019832) Treponema pallidum Ab [Presence] in Serum
115
881
1.34
2.22
1.6
1.7
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
17
80
2.14
2.19
1.1
1.3
g/l
3.1
2.9
0.17
11
56
(3024139) IgG subclass 3 [Mass/volume] in Serum
17
80
2.14
2.19
1.1
1.3
g/l
0.4
0.4
0.29
12
56
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
30
173
1.75
2.18
1.7
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
239
0.41
2.16
1.1
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
108
1.96
2.16
1.3
1.4
pmol/l
248.2
310.2
0.84
16
89
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
19
3.70
2.15
3.7
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
73
522
1.42
2.14
1.6
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
95
2.02
2.11
1.3
2.1
—
—
—
0
0
(44813793)
14
62
2.27
2.08
1.1
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
33
199
1.68
2.07
1.3
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
12
50
2.41
2.03
1.0
1.1
iu/ml
165.4
235.4
0.45
12
50
(3025018) Bordetella pertussis Ab [Titer] in Serum
12
50
2.41
2.03
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
193
1.68
2.01
1.3
1.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
26
148
1.77
1.99
1.3
1.7
g/l
0.7
0.9
0.40
19
118
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
472
4274
1.17
1.95
4.1
3.9
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
14
64
2.20
1.95
1.2
1.1
—
43.2
—
0
5
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
16
3.76
1.93
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
16
3.76
1.93
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
16
3.76
1.93
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
16
3.76
1.93
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
19
99
1.93
1.91
1.3
2.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
23
129
1.80
1.86
1.4
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
86
1.99
1.85
1.4
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
14
66
2.13
1.82
1.2
1.2
—
43.4
—
0
7
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
197
2318
0.82
1.79
2.2
2.8
ug/l
0.5
0.7
6.12
119
1380
(4062490)
16
81
1.99
1.75
1.1
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
133
1077
1.26
1.74
9.7
6.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
92
710
1.32
1.73
1.2
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
30
2.68
1.72
1.3
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
13
3.86
1.71
1.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
96
1.89
1.71
1.1
1.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
51
358
1.44
1.70
3.8
3.9
mmol/l
24.2
24.9
1.04
46
340
(4010399)
85
651
1.33
1.69
1.4
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
21
119
1.78
1.67
1.0
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
56
403
1.41
1.64
2.6
2.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
40
270
1.50
1.63
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
37
246
1.52
1.61
2.4
2.5
ug/min
445.9
90.3
1.00
19
157
(3014765) Yersinia sp identified in Stool by Organism specific culture
40
272
1.49
1.58
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
40
274
1.48
1.53
1.2
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
15
3.34
1.52
1.4
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
46
326
1.43
1.49
2.2
3.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
94
1.82
1.47
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
109
1.76
1.47
1.3
2.0
—
—
—
0
0
(3019225) pH of Specimen
100
801
1.27
1.46
5.2
4.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
28
2.51
1.45
1.4
2.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
52
2.13
1.44
1.4
1.3
nmol/l
153.8
146.2
0.11
11
52
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
21
125
1.69
1.44
1.0
1.3
nmol/l
0.6
0.6
0.03
21
119
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
16
3.13
1.44
1.0
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
45
321
1.42
1.42
2.3
2.2
ug/l
324.5
443.8
0.34
40
303
(3009542) Hematocrit [Volume Fraction] of Blood
962
9309
1.18
1.40
24.0
13.3
%
41.1
41.0
0.07
673
7228
(3022217) INR in Platelet poor plasma by Coagulation assay
127
1052
1.23
1.40
16.7
20.7
inr
1.1
1.2
0.55
23
145
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
19
111
1.72
1.39
1.1
1.3
nmol/l
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
29
2.42
1.39
2.6
2.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
67
1.95
1.38
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
67
1.95
1.38
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
67
1.95
1.38
1.3
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
61
797
0.75
1.37
1.5
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
23
2.62
1.37
3.7
3.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
17
2.95
1.36
2.0
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
62
473
1.33
1.32
1.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
34
2.36
1.29
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
69
1.89
1.29
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
69
1.89
1.29
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
69
1.89
1.29
1.3
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
35
2.29
1.27
3.6
2.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
44
2.05
1.27
1.0
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
92
746
1.25
1.24
9.4
10.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
48
356
1.36
1.23
1.3
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
9
45
2.01
1.23
1.1
1.1
u/l
88.0
89.0
—
9
39
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
19
2.64
1.21
1.4
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
38
2.11
1.18
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
19
117
1.63
1.18
2.4
2.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
57
1.94
1.17
1.3
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
13
72
1.81
1.15
1.2
1.2
nmol/l
324.9
416.2
—
7
64
(3038177) Helicobacter pylori Ab [Presence] in Serum
24
158
1.53
1.15
1.3
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
17
103
1.66
1.13
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
32
225
1.43
1.13
1.3
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
22
329
0.66
1.12
1.5
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
67
531
1.28
1.11
1.8
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
26
176
1.49
1.11
1.8
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
25
168
1.50
1.10
2.0
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
74
1.77
1.07
1.1
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
74
1.77
1.07
1.1
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
52
1.93
1.06
1.3
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
52
1.93
1.06
1.3
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
129
1.56
1.06
1.3
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
33
2.13
1.05
1.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
12
67
1.80
1.05
1.2
1.2
—
—
—
0
0
(4015189)
5
22
2.28
1.03
2.6
3.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
333
1.33
1.03
2.5
1.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
75
1.74
1.03
1.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
91
757
1.22
1.01
2.4
2.4
ug/l
4.8
7.8
2.76
73
684
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
35
2.01
1.00
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
75
612
1.24
1.00
1.1
1.2
iu/ml
67.4
169.6
3.71
24
254
(3049717) Cytology report of Urine Cyto stain
44
335
1.33
1.00
2.0
2.6
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
13
76
1.72
0.99
1.1
1.4
mmol/l
15.0
12.0
—
7
20
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
61
1.81
0.98
1.1
2.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
131
1510
0.85
0.98
2.6
3.0
mmol/l
2.5
2.4
1.92
121
1336
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
23
2.18
0.98
1.0
2.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
84
1.67
0.98
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
149
1.49
0.96
1.2
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
65
525
1.25
0.95
3.6
2.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
52
1.74
0.92
1.3
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
52
1.74
0.92
1.3
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
52
1.74
0.92
1.3
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
52
1.74
0.92
1.3
2.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
28
2.15
0.91
1.8
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
56
448
1.26
0.90
1.5
2.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
71
1.70
0.89
1.5
2.0
u/field
2.5
2.1
—
6
37
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
127
1.50
0.89
1.3
1.9
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
42
1.91
0.88
1.1
2.7
—
56251.6
—
0
8
(3004775) Volume in Urine collected for unspecified duration
13
79
1.65
0.88
1.5
2.5
ml
935.9
631.6
—
8
52
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
100
1166
0.84
0.88
1.7
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
286
3103
0.90
0.87
3.2
3.7
%
22.8
21.0
0.86
101
1305
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
8
43
1.87
0.87
1.1
1.1
u/l
24.9
15.3
—
8
36
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
30
2.00
0.87
1.2
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
64
1.73
0.86
1.0
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
307
2837
1.11
0.85
2.6
2.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
72
1.67
0.85
1.3
1.4
e6/l
35771.7
41783.6
—
6
40
(3017569) Oxygen content in Arterial blood
8
45
1.78
0.84
1.8
3.5
—
—
—
0
0
(4281824)
12
73
1.65
0.81
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
116
1010
1.16
0.81
8.7
9.5
mmol/l
0.8
1.1
0.40
92
816
(21494434) Karyotype in Bone marrow
13
81
1.61
0.81
1.1
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
47
1.71
0.80
1.1
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
25
182
1.38
0.78
1.6
1.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
27
0.00
0.77
0.0
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
39
305
1.29
0.77
2.2
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
34
1.77
0.76
1.2
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
166
1.39
0.76
1.3
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
59
1.70
0.76
1.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
59
1.70
0.76
1.3
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
161
0.62
0.75
1.2
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
53
1.70
0.75
1.2
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
91
1.54
0.75
1.4
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
91
1.54
0.75
1.4
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
91
1.54
0.75
1.4
1.8
—
—
—
0
0
(44806420)
5
24
2.09
0.74
2.0
2.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
54
1.67
0.74
1.0
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
210
1.34
0.74
1.8
1.5
u/ml
102.8
124.1
—
10
40
(1001926) Buprenorphine [Presence] in Urine by Screen method
47
379
1.25
0.74
1.6
2.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
38
1.85
0.73
5.9
2.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
58
480
1.22
0.73
1.5
2.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
171
0.64
0.72
1.7
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
310
2891
1.10
0.72
2.7
3.4
mmol/l
2.3
2.4
0.29
277
2592
(3019060) Gas panel - Arterial blood
68
573
1.20
0.71
6.1
6.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
57
1.58
0.71
1.2
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
57
473
1.22
0.70
1.5
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.3
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.3
2.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
228
0.70
0.70
1.7
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
93
1.51
0.69
1.4
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
222
1.31
0.68
1.2
1.2
u/ml
289.5
264.1
0.22
24
140
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
42
1.67
0.68
1.3
2.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
52
626
0.82
0.68
2.4
2.8
ng/l
122.1
171.2
0.98
44
570
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
7
117
0.60
0.68
1.4
1.1
%
80.9
96.9
—
7
109
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
156
0.64
0.67
1.5
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
58
485
1.21
0.67
1.5
2.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
136
1.40
0.67
1.2
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
30
232
1.30
0.66
1.1
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
155
0.64
0.66
1.5
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
154
1.37
0.65
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
58
487
1.20
0.65
1.5
2.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
28
216
1.30
0.63
1.5
3.6
—
—
—
0
0
(3000492) Spirometry study
121
1080
1.13
0.63
1.5
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
50
415
1.21
0.63
1.3
1.4
iu/l
24.9
27.7
0.26
43
349
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
79
1.52
0.62
1.2
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
30
1.67
0.61
1.0
2.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
44
362
1.22
0.61
1.9
1.9
pmol/l
189.2
218.3
1.47
37
345
(3045716) Anion gap in Serum or Plasma
8
51
1.57
0.60
1.5
3.5
mmol/l
8.1
9.4
—
8
40
(4306422)
11
163
0.67
0.60
1.4
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
21
0.00
0.60
0.0
5.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
18
131
1.38
0.59
1.4
1.3
mmol/l
7.7
7.3
0.13
13
89
(3027944) Amphetamines [Presence] in Urine
56
474
1.19
0.59
1.5
2.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
22
166
1.33
0.59
1.1
1.1
—
8.1
—
0
14
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
162
0.68
0.58
1.5
1.4
—
—
—
0
0
(3020891) Body temperature
43
355
1.22
0.58
4.8
5.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
8
54
1.48
0.57
1.0
1.1
—
12.5
—
0
6
(40768795) Lymph node Pathology biopsy report
12
81
1.49
0.57
1.2
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
22
167
1.32
0.57
1.5
1.3
u/l
15.1
40.9
1.60
22
143
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
55
1.46
0.56
1.3
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
34
275
1.24
0.55
1.3
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
100
891
1.13
0.55
3.2
2.5
u/l
36.2
94.5
0.57
95
775
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
10
65
1.54
0.55
1.7
2.6
e9/l
0.3
0.2
—
10
59
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
123
1111
1.12
0.55
1.5
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
38
1.58
0.54
1.7
1.3
mmol/l
5.6
6.4
—
6
38
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
62
535
1.17
0.53
2.0
3.4
pmol/l
4.3
4.6
1.84
52
480
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
62
1.46
0.53
1.7
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
62
1.46
0.53
1.6
1.4
—
—
—
0
0
(4024509)
9
62
1.46
0.53
1.4
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
203
0.74
0.52
1.3
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
40
1.50
0.51
1.8
2.9
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
40
1.50
0.51
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
50
584
0.85
0.51
1.5
1.6
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
41
1.47
0.50
1.2
2.8
ug/l
13.2
16.9
—
6
35
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
84
1.43
0.49
1.2
1.6
g/l
1.1
1.0
0.45
12
84
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
10
68
1.47
0.47
1.7
2.5
e6/l
327.6
626.0
—
10
60
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
111
1.36
0.46
1.3
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
111
1.36
0.46
1.3
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
39
328
1.20
0.46
1.4
1.4
u/l
7.8
8.0
0.02
32
269
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
49
421
1.17
0.46
1.8
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
77
1.43
0.45
1.1
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
18
138
1.31
0.45
1.1
1.6
nmol/l
0.3
0.3
0.31
12
113
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
165
1.28
0.45
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
165
1.28
0.45
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
112
1.34
0.44
1.2
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
7
51
1.37
0.44
1.0
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
51
1.37
0.44
2.1
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
51
1.37
0.44
2.4
3.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
51
1.37
0.44
1.1
1.6
—
—
—
0
0
(4034850)
25
306
0.81
0.43
8.6
9.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
35
295
1.19
0.42
3.1
2.7
g/l
3.3
3.7
0.88
35
280
(3017509) Phencyclidine [Presence] in Urine
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
34.3
—
0
9
(3029396) Erythrocyte agglutination [Presence] in Blood
0
16
0.00
0.41
0.0
2.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(4146454)
12
88
1.37
0.40
2.0
2.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
18
0.00
0.40
0.0
2.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
160
0.75
0.40
1.6
1.2
u/ml
3.4
5.1
—
5
68
(3023410) Appearance of Cerebral spinal fluid
7
105
0.66
0.39
1.3
1.7
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
2.4
—
1.1
—
0
13
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
115
1.31
0.39
1.2
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
36
1.39
0.38
1.2
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
158
0.76
0.37
1.5
1.2
u/ml
4.5
3.8
—
6
49
(40768806) Pleura Pathology biopsy report
10
72
1.39
0.37
1.4
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
272
1.18
0.36
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
189
1.22
0.36
1.4
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
6
42
1.43
0.35
1.2
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
13
99
1.32
0.35
1.2
1.5
mosm/kgh2o
278.6
285.1
—
7
79
(4035726)
83
757
1.10
0.35
1.4
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.2
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
219
1.19
0.33
1.3
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
19
155
1.23
0.32
1.3
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
47
1.28
0.32
1.2
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
47
1.28
0.32
1.2
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
92
1.31
0.32
1.5
1.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
54
1.30
0.30
3.3
3.2
u/ml
786.0
1176.5
—
7
54
(3016018) Differential panel - Cerebral spinal fluid
13
102
1.28
0.30
1.2
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
110
0.73
0.29
1.5
1.5
—
—
—
0
0
(4094501)
32
279
1.15
0.28
1.1
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
10
76
1.32
0.28
1.5
3.2
%
45.8
43.5
—
5
22
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
8
64
1.25
0.27
1.5
1.7
u/l
5.1
6.8
—
8
49
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
113
1.24
0.26
1.2
1.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
8
67
1.20
0.26
2.5
3.2
u/ml
27.2
59.3
—
8
67
(3005570) Glucose [Moles/volume] in Urine
11
86
1.28
0.26
1.5
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
72
1.25
0.25
1.2
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
73
1.23
0.25
1.3
2.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
114
1.23
0.25
1.2
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
114
1.23
0.25
1.2
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
398
3879
1.04
0.24
3.5
4.3
ug/l
1.5
2.1
4.14
355
3538
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
40
443
0.90
0.23
1.9
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
115
1.22
0.23
1.2
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
8.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
21
182
1.16
0.21
1.2
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
156
0.83
0.21
1.5
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
104
0.77
0.21
1.3
1.3
—
—
—
0
0
(4268621)
8
104
0.77
0.21
3.3
2.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
30
334
0.90
0.20
1.4
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
6
50
1.20
0.19
1.7
1.2
—
—
—
0
0
(1002224) Polysomnography panel
59
549
1.08
0.19
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
41
375
1.10
0.19
1.4
1.5
mu/l
238.7
275.2
0.66
34
342
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
166
1.15
0.18
1.7
3.5
—
3309.9
—
0
13
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
258
0.89
0.18
1.5
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
19
216
0.88
0.17
1.6
1.4
e6/l
60.9
24.5
0.27
14
168
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
66
0.76
0.17
1.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
68
1.18
0.16
2.3
4.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
113
1083
1.05
0.16
4.4
4.2
%
28.1
30.9
2.41
85
742
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
89
848
1.05
0.16
3.4
4.5
ug/l
59.8
16.8
0.37
71
691
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
37
341
1.09
0.16
3.8
3.6
u/ml
94.2
3986.7
0.76
32
299
(3003694) ABO and Rh group [Type] in Blood
277
2706
1.03
0.16
1.4
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
13
151
0.86
0.15
1.1
1.0
u/ml
11.0
2.5
—
6
60
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
80
1.13
0.15
1.6
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
17
191
0.89
0.14
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
17
191
0.89
0.14
1.3
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
107
0.84
0.13
1.2
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
17
190
0.89
0.13
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
17
190
0.89
0.13
1.3
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
198
0.91
0.10
1.1
1.1
u/ml
0.8
2.6
—
7
80
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
110
1067
1.03
0.10
1.9
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
280
1.07
0.10
2.4
2.9
u/ml
0.3
0.4
0.79
17
148
(3042733) HLA Ab [Presence] in Serum
5
45
1.11
0.10
4.8
5.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
46
1.09
0.09
1.4
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
46
1.09
0.09
1.4
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
27
289
0.93
0.09
2.9
2.7
%
214.4
186.0
0.67
27
276
(3051611) Lipemic interference index of Serum or Plasma
10
87
1.15
0.09
2.2
3.9
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
48
1.04
0.09
1.2
1.7
—
1224630.0
—
0
5
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
48
1.04
0.09
1.8
1.9
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
5
48
1.04
0.09
2.0
1.7
—
21.0
—
0
5
(3024891) Influenza virus A+B Ag [Presence] in Specimen
30
282
1.07
0.09
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
55
1.09
0.09
2.5
1.3
—
—
—
0
0
(4198724)
5
60
0.83
0.08
2.0
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
62
0.81
0.08
2.2
2.1
—
—
—
0
0
(4027681)
5
63
0.79
0.08
1.8
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
19
205
0.93
0.08
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
70
0.86
0.07
1.2
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
75
0.80
0.07
2.2
2.1
%
12.8
11.4
—
6
75
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
186
1.08
0.07
1.1
1.1
u/ml
1.3
6.4
2.68
13
93
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
82
0.85
0.07
1.1
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
21
196
1.07
0.07
1.3
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
204
0.93
0.07
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
88
1.02
0.07
3.1
2.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
109
1.10
0.06
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
119
1168
1.02
0.06
1.4
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
119
1.09
0.06
1.2
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
167
1694
0.98
0.05
3.7
3.6
ng/l
705.8
606.7
0.13
111
1267
(3023430) Cat dander IgE Ab [Units/volume] in Serum
13
141
0.92
0.05
1.1
1.1
u/ml
0.7
3.4
—
6
56
(3017446) Testosterone [Moles/volume] in Serum or Plasma
111
1090
1.02
0.05
2.2
2.3
nmol/l
14.2
13.6
0.33
102
995
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
222
2198
1.01
0.04
2.7
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
229
1.05
0.04
1.5
1.9
iu/l
2.5
5.1
—
8
83
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
131
1.07
0.03
1.9
1.7
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
13
139
0.93
0.03
2.2
2.3
—
1088.0
—
0
10
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
28
271
1.03
0.02
1.5
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
61
619
0.98
0.02
1.2
1.3
—
50.2
—
0
29
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
117
0.94
0.01
1.2
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
119
1182
1.01
0.01
1.5
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
114
1.05
0.00
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
166
0.96
0.00
1.0
1.0
u/ml
3.2
1.9
—
7
76
(3024928) Oxygen saturation in Venous blood
20
194
1.03
0.00
2.4
2.8
—
—
—
0
0
(44790047)
12
116
1.03
0.00
1.2
1.8
—
—
—
0
0
(44790048)
12
116
1.03
0.00
1.2
1.8
—
—
—
0
0
(44806118)
12
116
1.03
0.00
1.3
1.8
—
—
—
0
0
(44790049)
12
116
1.03
0.00
1.3
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
17
174
0.98
0.00
1.1
1.1
u/ml
0.2
1.8
—
9
71
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
98
1.02
0.00
1.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
128
1.02
0.00
2.7
2.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
119
1186
1.00
0.00
2.1
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
49
488
1.00
0.00
12.6
13.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
135
1.04
0.00
1.1
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
50
1.00
0.00
1.2
2.5
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
50
1.00
0.00
1.8
2.0
nmol/l
121.8
125.0
—
5
44
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
4.6
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
88
0.91
0.00
4.1
3.9
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
8
0.00
0.00
0.0
5.1
—
407.6
—
0
8
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
0.1
—
0
6
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
78
0.90
0.00
1.1
1.5
—
74.5
—
0
8
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
397.3
—
0
8
(3025315) Body weight
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
6.4
—
0
8
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
6
62
0.97
0.00
5.2
9.2
u/ml
—
57.8
—
0
27
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
72.4
—
0
5
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
466.8
—
0
6
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
11.4
—
0
8
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
71
0.99
0.00
1.3
1.1
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
49
490
1.00
0.00
1.3
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
120
1.00
0.00
1.4
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint PSORI_STRICT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| PSORI_STRICT | 1.781 [1.33, 2.39] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.162 |
During the follow-up period (1.1.1998 — 31.12.2019), 80 out of 1071 females with PSORI_STRICT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| PSORI_STRICT | 1.697 [1.39, 2.07] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.047 |
During the follow-up period (1.1.1998 — 31.12.2019), 192 out of 2080 males with PSORI_STRICT died.
Mortality risk
Mortality risk for people of age
years, who have PSORI_STRICT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.142% | 0.38% |
| 5 | 1.044% | 2.072% |
| 10 | 2.618% | 5.097% |
| 15 | 5.037% | 10.192% |
| 20 | 8.678% | 17.05% |
Relationships between endpoints
↥Index endpoint: PSORI_STRICT – Psoriasis (vulgaris), strict definition
GWS hits: 7
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data